Tenofovir Alafenamide (Taf)

Form: Tablet

Strength: 25 mg TAF per tablet

Reference Brands: Vemlidy® (EU & US)

Category: Hepatitis

Tenofovir Alafenamide (TAF) is a next-generation nucleotide reverse transcriptase inhibitor (NRTI) used for the treatment of chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets, typically in 25 mg strength, TAF delivers higher intracellular concentrations of the active drug with lower plasma exposure, improving safety and reducing kidney and bone side effects compared to Tenofovir Disoproxil Fumarate (TDF). Marketed under the brand name Vemlidy® (for HBV) and as part of combination therapies for HIV, TAF is FDA- and EMA-approved, widely used by pharma B2B suppliers and healthcare providers in the US and EU.